Forward - looking statements

Search documents
Enduro Metals Announces Extension to Deadline to Complete Second Tranche of Financing
Newsfile· 2025-08-29 21:00
Group 1 - Enduro Metals Corporation has received a 30-day extension from the TSX Venture Exchange to complete the final documentation for its non-brokered private placement offering, now due by September 29, 2025 [1] - The first tranche of the financing was successfully closed on August 19, 2025, raising a total of $2,730,477 [1] - The company is currently finalizing the closing process for the second and final tranche, with all orders already received [1] Group 2 - Enduro Metals is focused on its Newmont Lake Project, which spans a total area of 688 km² located in British Columbia's Golden Triangle [2] - The geological team has identified multiple deposit environments of interest within the Newmont Lake Project, including high-grade epithermal/skarn gold and copper-gold alkalic porphyry mineralization [2]
37 Capital Closes First Tranche of Private Placement
Newsfile· 2025-08-29 21:00
Vancouver, British Columbia--(Newsfile Corp. - August 29, 2025) - 37 Capital Inc. (CSE: JJJ) ("37 Capital" or the "Company"). Further to the Company's new releases dated July 23, 2025 and July 30, 2025, the Company has closed the first tranche of the equity financing for total gross proceeds of $178,500 and issued 2,550,000 units at the price of $0.07 per unit. Each unit consists of one common share of the Company and one share purchase warrant to acquire one common share of the Company at a price of $0.10 ...
Mine Permit Received Approving Mount Polley’s Life of Mine Plan
Globenewswire· 2025-08-29 20:55
VANCOUVER, British Columbia, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Imperial Metals Corporation (the “Company” or “Imperial”) (TSX:III) reports that the Province of British Columbia has issued a permit amendment to allow expansion and extension of mining activities at the Mount Polley Mine (“Mount Polley”) in south-central British Columbia. Issuance of the permit amendment followed consent by both the Minister of Mining and Critical Minerals and the Minister of Environment and Parks under Mount Polley’s environm ...
Scandium Canada Announces a Private Placement of $500,000
Thenewswire· 2025-08-29 20:30
August 29, 2025 – TheNewswire - MONTRÉAL (QUÉBEC) – Scandium Canada Ltd. (TSX-V: SCD) (the “Corporation”) announces its intention to complete a non-brokered private placement for proceeds of $500 000 (the “Offering”). This Offering consist of the issuance of 20,000,000 units of the Corporation (the “Units”) at a price of $0.025 per Unit. Each Unit consists of one common share of the Corporation (the “Common Shares”) and one Common Share purchase warrant (the “Warrants”). Each Warrant entitles the holder th ...
DIH Holding US, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q
Globenewswire· 2025-08-29 20:30
NORWELL, Mass., Aug. 29, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. (“DIH” or the “Company”) (NASDAQ:DHAI) received a notice on August 26, 2025, from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”), which stated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) because it had not filed its Report on Form 10-Q for the period ended June 30, 2025 (the “Form 10-Q”), and because the Company remains delinquent in filing its Form 10-K for the year ended March ...
Panoro Announces Cancellation of LIFE Offering
Newsfile· 2025-08-29 20:19
Core Viewpoint - Panoro Minerals Ltd. has canceled its previously announced C$10,000,000 brokered private placement due to unfavorable market conditions and is exploring alternative financing options [1][2]. Group 1: Financing and Project Development - The net proceeds from the canceled LIFE Offering were intended for infill drilling, metallurgical testing, pre-feasibility engineering, and an updated preliminary economic assessment (PEA) for the Cotabambas Project [1]. - The company is in advanced discussions regarding alternative financing options, including the receipt of a third payment from the sale of the Antilla Project and the sale of a non-core exploration project [2]. - The Cotabambas Project contains an estimated 3.3 million ounces of gold in the indicated category and 2.7 million ounces in the inferred category, along with 3.8 billion pounds of copper in the indicated category and 3.0 billion pounds in the inferred category [2]. Group 2: Market Conditions and Project Valuation - The updated PEA will incorporate current gold prices exceeding $3,400 per ounce and copper prices over $4.40 per pound, which are expected to significantly enhance the value of the Cotabambas Project [2]. - The company anticipates receiving a third payment from the Antilla Project sale in 2025, along with a contingent payment based on the estimated NPV of the project [4]. Group 3: Strategic Alternatives and Corporate Focus - Panoro is evaluating potential strategic alternatives with various parties to advance the Cotabambas Project towards construction and operation [5]. - The company remains focused on completing its technical objectives, including project optimization studies that will contribute to the PEA and define the scope for the prefeasibility study for the Cotabambas Project [3].
Horizon Bancorp, Inc. Announces Completion of $100 Million Subordinated Notes Offering
Globenewswire· 2025-08-29 20:01
MICHIGAN CITY, Ind., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Horizon Bancorp, Inc. (NASDAQ: HBNC) (“Horizon”), the parent company of Horizon Bank, today announced the completion of a private placement of $100,000,000 in aggregate principal amount of 7.00% Fixed-to-Floating Rate Subordinated Notes due 2035 (the “Notes”). Horizon intends to use the net proceeds of the private placement for general corporate purposes, including in support of the potential repositioning of its balance sheet, and to redeem approximate ...
Strata Critical Medical to Present at the 2025 Jefferies Industrials Conference
Globenewswire· 2025-08-29 16:00
NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or the “Company”), formerly known as Blade Air Mobility, Inc. (Nasdaq: BLDE) today announced that Will Heyburn, Co-Chief Executive Officer and Chief Financial Officer, will present at the 2025 Jefferies Industrials Conference on Thursday, Sept 4, 2025 at 11:30am ET. A webcast of the event will be available at the link here. A replay will be available shortly after the conclusion of the presentation on the inves ...
GCL Announces Audited Financials of Ban Leong and Unaudited Pro Forma Combined Financials
Globenewswire· 2025-08-29 13:00
Core Viewpoint - GCL Global Holdings Ltd has completed the acquisition of Ban Leong Technologies Limited through its subsidiary Epicsoft Asia, and has filed a Form 6-K with the SEC detailing this transaction [1][7]. Company Overview - GCL Global Holdings Ltd is a prominent provider of games and entertainment, focusing on immersive experiences and engaging content for gaming communities, particularly in the rapidly growing Asian gaming market [3][4]. - Epicsoft Asia, a subsidiary of GCL, is a leading distributor of interactive entertainment software, with a strong network and successful track record in game launches across Taiwan, Hong Kong, and Southeast Asia [4]. - Ban Leong Technologies Limited, incorporated in Singapore in 1993 and listed on the Singapore Stock Exchange in 2005, specializes in the wholesale and distribution of computer peripherals and multimedia products, with key segments including IT accessories and gaming [5]. Financial Information - The Form 6-K includes audited financial statements for Ban Leong for the fiscal years ending March 31, 2024, and March 31, 2025 [7]. - It also presents unaudited pro forma condensed combined statements of income and comprehensive income, reflecting the business acquisition as if it had occurred on April 1, 2024, and a combined balance sheet as of March 31, 2025 [7].
Pasithea Therapeutics Updates Time of Presentation at the H.C. Wainwright 27th Annual Global Investment Conference
Globenewswire· 2025-08-29 12:39
Core Points - Pasithea Therapeutics Corp. is a clinical-stage biotechnology company focused on developing PAS-004, a next-generation macrocyclic MEK inhibitor for treating RASopathies and MAPK pathway-driven tumors [2] - The company will present at the H.C. Wainwright 27 Annual Global Investment Conference on September 8, 2025, at 5:00 PM ET [1][2] - PAS-004 is currently undergoing a Phase 1 clinical trial for advanced cancer patients and a Phase 1/1b clinical trial for adult patients with neurofibromatosis type 1-associated plexiform neurofibromas [2] Event Details - The presentation will take place at the Lotte New York Palace Hotel during the H.C. Wainwright 27 Annual Global Investment Conference [2] - Management will be available for one-on-one meetings throughout the event [2]